Navigation Links
Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation
Date:3/13/2008

- Product Sales of $90 Million to $120 Million Expected in 2008 - Initial Results from JZP-6 Phase III Clinical Trial Expected by Year End - New Data Provided on Pipeline and Early-Stage Development Portfolio

- 2008 Financial Guidance Provided

PALO ALTO, Calif., March 13 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today provided a comprehensive update on its commercial activities and near-term product development pipeline, and provided 2008 financial guidance, for investors and analysts at its Investor Day meeting in New York City.

"Jazz Pharmaceuticals' strategy combines a strong commercial presence with a rapidly advancing product development pipeline addressing important patient needs in neurological and psychiatric disorders," said Samuel R. Saks, M.D., Chief Executive Officer. "With the anticipated launch of LUVOX CR later this month, continued strong performance from our XYREM sales efforts, top-line results from our first Phase III clinical study of JZP-6 for fibromyalgia syndrome and progress across our R&D portfolio, 2008 is positioned to be a transformational year for Jazz Pharmaceuticals."

Commercial Updates

Jazz Pharmaceuticals expects to launch once daily LUVOX(R) CR (fluvoxamine maleate) Extended-Release Capsules with shipments to wholesalers by the end of March. The product was approved by the U.S. Food and Drug Administration (FDA) on February 28, 2008 for the treatment of obsessive compulsive disorder (OCD) and social anxiety disorder (SAD). LUVOX CR will be priced to wholesalers at $3.25 per capsule for 100 mg and 150 mg strengths. Ex-factory sales of LUVOX CR are expected to be in the range of $40 million to $60 million during 2008.


'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
2. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
3. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
4. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
5. Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
6. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
7. Jazz Pharmaceuticals, Inc. Announces Submission of Complete Response to FDA Approvable Letter for LUVOX(R) CR
8. Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
9. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
10. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
11. American Stock Exchange LLC to Delist Securities of Samaritan Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Follow us on LinkedIn – ... abutments and dentures are used to provide relief to ... missing teeth. The growth in the global market for ... aging global population, expanding number of edentulous people and ... population being edentulous or completely toothless, there is immense ...
(Date:3/6/2015)... 2015 Ticket Down is a reputable source ... exchange has extended their customer appreciation discount code ED-SHEERAN-2015 for ... Yorkshire England and he began his career in the music ... couple of years Ed Sheeran has become a household name. ... on stage he is having the time of his life ...
(Date:3/6/2015)... Parents need to start the discourse ... use disorders. School programs like DARE, or Drug Abuse ... or Narcotics Overdose Prevention and Education has already impacted ... News on Feb. 27th. As teens continue to ... drug prevention proponents are lobbying Florida to pass The ...
(Date:3/6/2015)... Further solidifying their position as a healthcare ... that the company has earned Inavero’s Best of Staffing® ... Talent Award five years in a row. Presented in ... winners are proven industry leaders in service quality based ... they have helped find temporary and permanent jobs. With ...
(Date:3/6/2015)... As the Association of American Medical Colleges' ... by 2025 is updated this week and debated in ... preparing by analyzing demographics and pursuing viable solutions for ... factors including the increasing number of retiring doctors, increasing ... Care Act and an uneven distribution of new doctors ...
Breaking Medicine News(10 mins):Health News:Aging Population & Emphasis on Dental Care Drives the Dental Prosthetic & Implant Consumables Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population & Emphasis on Dental Care Drives the Dental Prosthetic & Implant Consumables Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Ed Sheeran Tickets in Indianapolis, Austin, Albany, St. Louis, London, Des Moines, Salt Lake City, Saskatoon, Regina and Denver/Morrison Now On Sale at Ticket Down 2Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4
... Colo., Sept. 11 ,Spectranetics Corporation (Nasdaq: SPNC ... A.G. Edwards Growth Conference, which is being held,September ... John G. Schulte, Spectranetics, president and chief executive ... at 9:30 a.m. Eastern time,(7:30 a.m. Mountain time) ...
... Board of Directors of,Bristol-Myers Squibb Company (NYSE: BMY ... per share on the $.10 par value,Common Stock of ... 1, 2007 to stockholders of record at the close ... declared a quarterly dividend of fifty cents ($0.50),per share ...
... Sept. 11 Washington state nursing,leader Sally Watkins, ... of,Nursing Practice, Education, and Research by the Washington ... professional nurses,association and union. "We are very ... leader,who will be a strong patient and nurse ...
... nuclear power industry is riding the green wave back ... solution to our growing energy needs. But even as ... realistically play, it is bound by a global energy ... by the marketplace. , Veteran New York Times ...
... a third of prostate biopsies resulted in a cancer ... Men whose first biopsy did not find cancer often ... chance of a cancer diagnosis. , While PSA ... cancer screening, a biopsy is what actually determines the ...
... at the University of Oregon and requiring no more ... after a doctors appointment is credited with a 224-percent ... mild developmental delays in a yearlong study. , Researchers ... referrals for special services or additional monitoring would not ...
Cached Medicine News:Health News:Spectranetics to Present at The A.G Edwards Growth Conference on September 18 2Health News:New Director of Nursing Practice Named for Nurses Association 2Health News:Trade-offs reveal no clear favorites in alternative energy market 2Health News:Other highlights in the September 11 JNCI 2Health News:Other highlights in the September 11 JNCI 3Health News:Parental surveys boost diagnosis abilities of pediatricians 2Health News:Parental surveys boost diagnosis abilities of pediatricians 3
(Date:3/6/2015)... 2015  The German Court of Appeal has ruled that ... regimen patent for Alimta® (pemetrexed disodium) would not be infringed ... salt form of pemetrexed in Germany ... The German Court ruled in favor of the generic ... Actavis. This decision vacated the prior decision of the Regional ...
(Date:3/6/2015)... , Mar. 06, 2015 Research and Markets ... of the "European Patient Handling Equipment Market by ... User - Forecast to 2019" report to their ... market is expected to grow at a double-digit CAGR ... Factors such as rising geriatric population, increasing ...
(Date:3/5/2015)... -- BioLineRx (NASDAQ: BLRX ; TASE: ... in-licensing and developing promising therapeutic candidates, today announced ... of American Depositary Shares ("ADSs"), each representing ten ... ADSs in the offering are to be sold ... acting as sole book-running manager for the offering.  ...
Breaking Medicine Technology:German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit 2German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit 3European Patient Handling Equipment (Wheelchair, Scooters, Bathroom Safety Supply, Mechanical, Ambulatory) Market 2015-2019 2European Patient Handling Equipment (Wheelchair, Scooters, Bathroom Safety Supply, Mechanical, Ambulatory) Market 2015-2019 3BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3
... 17, 2011 Bayer HealthCare LLC announced today that ... between Bayer and Farnam Companies Inc. over Farnam,s advertising ... As part of the settlement, Farnam has agreed to ... online advertising campaign included claims that Bio Spot® was ...
... 17, 2011 aTyr Pharma , an innovative ... named the company as a winner of the 2011 ... honoring the year,s most promising private companies. aTyr was ... of Physiocrines and development of Physiocrine-based medicines. Physiocrines are ...
Cached Medicine Technology:Bayer Announces Farnam Companies' Agreement to Halt Disputed Bio Spot® Ads 2aTyr Pharma Honored with Red Herring 100 North America Award for Discovering and Developing Innovative Medicines Based on Physiocrine Biology 2
... Brilliance 64-channel configuration breaks through previous ... volume, thin-slice coverage to improve diagnostic ... ,With 40mm of thin-slice coverage, the ... allowing for unprecedented coronary artery evaluation. ...
Assay for Anti-HTLV-I and Anti-HTLV-II...
InBios' Trypanosoma cruzi (chagas disease) is an ELISA system for the detection of antibodies to T.cruzi derived TcF antigen in human serum or plasma This test is intended for professional in vitro d...
... most flexible meter for Point ... hospitals. Accu-Chek Inform System offers ... is the only Point of ... for the entry and automatic ...
Medicine Products: